Vertex Pharmaceuticals Incorporated announces an Equity Buyback for $500 million worth of its shares.

Vertex Pharmaceuticals Incorporated (NasdaqGS:VRTX) commences a share repurchase program. Under the program, the company will repurchase $500 million worth of its shares. The purpose of the program is to reduce the impact of dilution from employee equity programs. The program will run over a period of 2 years and will terminate on December 31, 2019.